» Articles » PMID: 34833357

Predictors of Atrial Fibrillation Recurrences After a First Radiofrequency Catheter Ablation Intervention for Paroxysmal Atrial Fibrillation-Experience of a Low Volume Ablation Centre

Overview
Publisher MDPI
Specialty General Medicine
Date 2021 Nov 27
PMID 34833357
Authors
Affiliations
Soon will be listed here.
Abstract

Atrial fibrillation recurrences (AFR) after radiofrequency catheter ablation (RFCA) are not uncommon, up to 65% of patients having relapses in the first year. However, current data are based mainly on studies from centres with a large volume of ablations, as they include technically inhomogeneous interventions, and populations with different types of AF. The aim of our study was to assess and stratify the risk at 6 and 12 months for AFR after a single RFCA, in patients with paroxysmal AF, in a centre with low volume activity. We enrolled 40 patients who underwent an initial RFCA, followed by continuous 48 h ECG monitoring at 1, 3, 6, and 12 months. Patients self-monitored their cardiac activity by random daily radial pulse palpation or in the presence of palpitations. Ten independent predictors for late AFR were identified, and a 6-month risk score was computed using three of them: AFR duration in the first month, number of AFR between 1 and 3 months, and supraventricular ectopics per 24 h at 6 months. The score can explain 59% of the AFR ( = 0.001). A further 12-month assessment identified three independent predictors. The presence of AFR between 6-12 months is the most important of them (OR = 23.11, 95% CI = 3.87-137.83, = 0.001), explaining 45% of AFR over 1 year. The risk scores at 6 and 12 months were internally validated. The 6-month score proved to be a useful tool in guiding further strategy for patients with a low risk, while a longer follow-up to 12 months may avoid unnecessary early reinterventions.

References
1.
Faul F, Erdfelder E, Buchner A, Lang A . Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009; 41(4):1149-60. DOI: 10.3758/BRM.41.4.1149. View

2.
Wilber D, Pappone C, Neuzil P, de Paola A, Marchlinski F, Natale A . Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010; 303(4):333-40. DOI: 10.1001/jama.2009.2029. View

3.
Willems S, Khairy P, Andrade J, Hoffmann B, Levesque S, Verma A . Redefining the Blanking Period After Catheter Ablation for Paroxysmal Atrial Fibrillation: Insights From the ADVICE (Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination) Trial. Circ Arrhythm Electrophysiol. 2016; 9(8). DOI: 10.1161/CIRCEP.115.003909. View

4.
Narayan S, Krummen D, Shivkumar K, Clopton P, Rappel W, Miller J . Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol. 2012; 60(7):628-36. PMC: 3416917. DOI: 10.1016/j.jacc.2012.05.022. View

5.
Kornej J, Hindricks G, Shoemaker M, Husser D, Arya A, Sommer P . The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation. Clin Res Cardiol. 2015; 104(10):871-6. PMC: 4726453. DOI: 10.1007/s00392-015-0856-x. View